Farglory Life Insurance Co Ltd

Farglory Life Insurance Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to TWD 5.19 billion, representing 0.66% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, supported by a free cash flow of TWD 4.04 billion and total liabilities of TWD 722.33 billion. The debt-to-equity ratio is effectively zero, indicating minimal leverage and a conservative capital structure. Profitability metrics show a return on equity (ROE) of 7.27%, which is above the industry median of 5.8% for life and health insurers. However, the return on assets (ROA) of 0.59% is below the industry median of 0.8%, suggesting that asset utilization is a key area for improvement. The company's revenue is concentrated in its domestic market, with no disclosed international operations. This geographic concentration may expose the company to regulatory and economic risks specific to Taiwan. No material segment disclosures are available, but the company operates as a single business unit focused on life and health insurance. Farglory Life Insurance Co Ltd is projected to maintain stable growth, with revenue expected to increase by 2.1% in the current fiscal year and 1.8% in the following year. This growth is supported by a consistent operating cash flow of TWD 39.03 billion and a free cash flow margin of 10.1%. Risk factors are currently low, with no immediate liquidity or dilution concerns identified. The company has not issued any new shares in the past 12 months, and there are no active shelf registration statements or ATM programs. The risk assessment composite score is low, with no filing-based red flags detected. Recent events include the publication of the latest 10-K filing, which disclosed no material changes in business strategy or regulatory exposure. The company has not issued any press releases or held earnings calls in the past 90 days that would suggest a shift in operational or financial direction.